Home » Topics » Regulatory

Regulatory
RSS

FDA advisory committee supports efficacy of Prevnar in otitis media

May 23, 2002

Low-dose formulation of Retin-A Micro approved by FDA

May 23, 2002

FDA approves Zoloft for premenstrual dysphoric disorder

May 22, 2002

E.U. approval for Avonex for early use in high-risk MS patients

May 21, 2002

Actonel 35 mg approved for once-weekly dosing in postmenopausal osteoporosis

May 21, 2002

Paxil approved in Canada for posttraumatic stress disorder

May 17, 2002

Tacrolimus for psoriasis scheduled for marketing within three to four years

May 10, 2002

Positive pharmacokinetic results for buccal desmopressin

May 10, 2002

IND submitted for nitroglycerin lingual spray

May 10, 2002

Avalox i.v. cleared for market introduction in Germany

May 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.